Evaluation of the Effect of rTMS on Attention in Adults Diagnosed With Attention-Deficit Hyperactivity Disorder (ADHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00825708
Recruitment Status : Unknown
Verified January 2009 by Shalvata Mental Health Center.
Recruitment status was:  Recruiting
First Posted : January 21, 2009
Last Update Posted : January 21, 2009
Information provided by:
Shalvata Mental Health Center

Brief Summary:
The aim of the study is to evaluate the immediate effect of rTMS on attention in adults diagnosed with ADHD. the design is a double blind sham controlled crossover study.

Condition or disease Intervention/treatment Phase
Attention Deficit Hyperactivity Disorder Device: rTMS Device: shamTMS Not Applicable

Detailed Description:
The subjects were randomly assigned to two groups. group 1 starts with the real rTMS session followed within one week with a sham session. group 2 starts with a sham session and within one week recieve a real session. the subjects go through a neurocognitive evaluation before and after rTMS sessions and a clinical evaluation questionnaire modified for attention.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Outcomes Assessor)
Official Title: Evaluation of the Effect of rTMS on Attention in Adults Diagnosed With ADHD
Study Start Date : March 2007
Estimated Primary Completion Date : March 2008

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: rTMS
rTMS session
Device: rTMS
42 2 sec trains of 20HZ rTMS in 100% MT

Sham Comparator: SHAM
sham session
Device: shamTMS
sham TMS session

Primary Outcome Measures :
  1. PANNAS questionnaire modified for attention [ Time Frame: within one hour of the rTMS session ]

Secondary Outcome Measures :
  1. the CANTAB neurocognitive battery [ Time Frame: within 2 hours of the stimulation ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • age 18-65
  • diagnosis of ADHD according to DSM IV criteria

Exclusion Criteria:

  • other axis I diagnosis
  • risk factors for seizure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00825708

Contact: Eiran V Harel, MD 097478644

Shalvata MHC, cognitive and emotion lab Recruiting
Hod Hasharon, Israel
Principal Investigator: Yuval Bloch, MD         
Sponsors and Collaborators
Shalvata Mental Health Center

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Yuval Bloch, shalvataMHC Identifier: NCT00825708     History of Changes
Other Study ID Numbers: SH20107
First Posted: January 21, 2009    Key Record Dates
Last Update Posted: January 21, 2009
Last Verified: January 2009

Keywords provided by Shalvata Mental Health Center:

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Attention Deficit and Disruptive Behavior Disorders
Neurodevelopmental Disorders
Mental Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms